Aquablation therapy as a discussion point in patient counseling
“I think the key elements are that you should know about Aquablation if you are treating BPH in consideration for your patients and care, especially those who are looking for a more durable response and to maintain their ejaculation,” says Kevin Zorn, MD, FRCSC, FACS.
In this video, Kevin Zorn, MD, FRCSC, FACS, discusses future research on Aquablation therapy following the presentation of the study, “Aquablation for benign prostatic hyperplasia in large prostates (80-150CC): 3-year results,” at the 2021 American Urological Association annual meeting. Zorn is an associate professor of urology at the University of Montreal, Canada.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.
